Correction to: An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration

AAPS PharmSciTech. 2024 Mar 14;25(3):62. doi: 10.1208/s12249-024-02782-1.NO ABSTRACTPMID:38485865 | DOI:10.1208/s12249-024-02782-1
Source: AAPS PharmSciTech - Category: Drugs & Pharmacology Authors: Source Type: research